文献速递妇科产科

子宫内膜异位症女性恶性肿瘤风险显著增加

Markedly increased risk of malignancies in women with endometriosis.
PubMed 文献 · Gynecol Oncol · 2021-01-26

该回顾性全国人群队列研究利用韩国国民健康保险10年理赔数据库,纳入2010至2013年新诊断子宫内膜异位症患者179,865例,以同期因阑尾切除术但未诊断内异症者87,408例为对照。调整年龄、保险类型和合并症后,内异症组总体癌症风险显著升高(HR 1.34,95%CI 1.28-1.40,p<0.001),子宫、卵巢、宫颈、乳腺和甲状腺癌风险均显著增加,所有癌种诊断中位年龄<50岁。

要点

  • 内异症患者总体癌症风险较对照升高34%(HR 1.34,95%CI 1.28-1.40)
  • 子宫癌风险升高最显著(HR 4.59),其次为卵巢癌(HR 2.51)
  • 宫颈、乳腺和甲状腺癌风险亦显著增加,诊断中位年龄<50岁

核心结论

  • 子宫内膜异位症与总体癌症风险及子宫、卵巢、宫颈、乳腺、甲状腺癌风险增加相关。
  • 建议对子宫内膜异位症女性实施有效的癌症筛查以早期发现恶性肿瘤。

研究设计与样本

  • 纳入2010至2013年诊断的子宫内膜异位症患者179,865例,以同期行阑尾切除术但未诊断内异症者87,408例为对照。
  • 入组前均无癌症诊断,按ICD-10诊断码比较两组各器官部位癌症发生情况。

主要发现

  • 内异症组与对照组癌症发病率分别为644.3/10万人年和543.8/10万人年。
  • 调整年龄、保险类型和合并症后,内异症组总体癌症风险显著升高(HR 1.34;95%CI 1.28-1.40;p<0.001)。
  • 子宫癌风险HR 4.59(95%CI 3.56-5.91;p<0.001),卵巢癌HR 2.51(95%CI 1.99-3.16;p<0.001)。
  • 宫颈癌HR 1.84(95%CI 1.49-2.28;p<0.001),乳腺癌HR 1.44(95%CI 1.31-1.58;p<0.001),甲状腺癌HR 1.34(95%CI 1.24-1.45;p<0.001)。
  • 所有癌种诊断中位年龄均<50岁。

临床怎么用

  • 对子宫内膜异位症女性应重视癌症筛查,尤其关注子宫、卵巢、宫颈、乳腺和甲状腺。
  • 鉴于诊断中位年龄<50岁,筛查策略可考虑提前或加强覆盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the cancer risk in a cohort of women with newly diagnosed endometriosis. METHODS: This retrospective, nationwide, population-based cohort study utilized data from the 10-year claims database of the Korean National Health Insurance from January 2008 to December 2018. Patients diagnosed with endometriosis between 2010 and 2013 were included; those who underwent appendectomy but were not diagnosed with endometriosis during the study period served as controls. No participant was diagnosed with cancer before enrollment. Cancer diagnoses according to the International Classification of Diseases, 10th revision, were compared between the two groups. Cancer occurrence in both groups was identified according to the diagnostic codes for different organ sites. RESULTS: Altogether, 179,865 patients with endometriosis and 87,408 controls were analyzed, and the incidence rates of cancer were 644.3 and 543.8 per 100,000 person-years, respectively. Patients with endometriosis had a significantly increased overall cancer risk (hazard ratio [HR], 1.34; 95% confidence interval [CI], 1.28-1.40; p < 0.001) than controls after adjusting for age, insurance type, and comorbidities. They had significantly increased uterine (HR, 4.59; 95% CI, 3.56-5.91; p < 0.001), ovarian (HR, 2.51; 95% CI, 1.99-3.16; p < 0.001), cervical (HR, 1.84; 95% CI, 1.49-2.28; p < 0.001), breast (HR, 1.44; 95% CI, 1.31-1.58; p < 0.001), and thyroid cancer (HR, 1.34; 95% CI, 1.24-1.45; p < 0.001) risk. Median age at diagnosis was <50 years for all cancer types. CONCLUSIONS: Endometriosis was associated with an increased cancer risk, specifically uterine, ovarian, cervical, breast, and thyroid cancers, suggesting that effective cancer screening for early detection of malignancies in women should be implemented in those with endometriosis.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Eoh KJ, Han M, Kim EH, et al. Markedly increased risk of malignancies in women with endometriosis. Gynecol Oncol. 2021. PMID: 33514482. doi:10.1016/j.ygyno.2021.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。